Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.02	57.48	55.63	68.74	86.33	94.39
Cash & Short-Term Investments	41.02	57.48	55.63	68.74	86.33	94.39
Cash Growth	-23.14%	3.33%	-19.07%	-20.37%	-8.54%	-4.00%
Accounts Receivable	25.77	23.69	23.59	26.36	34.63	29.84
Inventory	22.84	18.79	23.81	24.43	39.77	36.01
Other Current Assets	3.94	3.4	10.62	43.78	8.83	8.29
Total Current Assets	93.56	103.36	113.65	163.31	169.55	168.53
Net Property, Plant & Equipment	65.15	66.26	64.68	65	78.98	68.56
Other Intangible Assets	1.65	1.65	2.49	2.58	74.6	82.38
Goodwill	7.89	8.05	7.13	7.57	7.34	7.78
Other Long-Term Assets	11.13	10.95	14.79	32.18	18.67	20.29
Total Assets	179.39	190.27	202.74	270.63	349.13	347.54
Accounts Payable	6.34	6.04	5.62	6.19	9.07	7.63
Accrued Expenses	14.63	15.87	13.57	14.07	18.84	17.85
Other Current Liabilities	-	-	4.12	10.8	-	4.32
Total Current Liabilities	20.97	21.91	23.31	31.06	27.91	29.8
Long-Term Leases	23.79	24.2	24.01	25.92	28.82	19.24
Other Long-Term Liabilities	0.73	0.7	1.43	1.39	6.83	11.42
Total Long-Term Liabilities	24.52	24.9	25.45	27.31	35.65	30.66
Total Liabilities	45.49	46.81	48.75	58.37	63.57	60.45
Common Stock	0.13	0.14	0.14	0.15	0.15	0.14
Additional Paid-in Capital	83.35	87.5	88.96	90.01	81.14	67.08
Accumulated Other Comprehensive Income	-5.31	-4.96	-6.78	-5.94	-6.44	-5.72
Retained Earnings	55.73	60.79	71.67	128.05	210.72	225.58
Shareholders' Equity	133.9	143.47	153.99	212.27	285.56	287.09
Total Liabilities & Equity	179.39	190.27	202.74	270.63	349.13	347.54
Total Debt	23.79	24.2	24.01	25.92	28.82	19.24
Net Cash (Debt)	17.23	33.29	31.62	42.83	57.51	75.15
Net Cash Growth	-48.25%	5.28%	-26.18%	-25.54%	-23.47%	-2.96%
Net Cash Per Share	1.21	2.32	2.15	2.92	3.89	5.13
Book Value	133.9	143.47	153.99	212.27	285.56	287.09
Book Value Per Share	9.37	10.01	10.46	14.48	19.31	19.62
Tangible Book Value	124.36	133.76	144.37	202.12	203.63	196.92
Tangible Book Value Per Share	8.71	9.33	9.81	13.79	13.77	13.46

SEC Filings: 10-K · 10-Q